AEYE Health has received the first-ever FDA clearance for a fully autonomous AI that can diagnose referable diabetic retinopathy using retinal images taken by a handheld camera, according to a company-issued press release.
This affordable and accessible solution is especially suited for point-of-care screening at clinics or at home, the company stated, and can help address the leading cause of blindness in working-age adults.
According to the release, AEYE diagnostic screening technology has already received FDA clearance and is commercially available with a tabletop imaging device. It is the